The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

1985

Stage

PIPE | IPO

About Theratech

Developer of advanced, controlled release drug delivery products which administer drugs through the skin, by oral delivery to the gastrointestinal tract, through tissues in the oral cavity, and by other means. Products provide significant advantages over existing controlled release drug delivery products and conventional oral, injectable, and continuous infusion methods by increasing efficacy, safety, bioavailability, and patient compliance and comfort. Research and development are focused on design and development of improved delivery systems for off-patent and proprietary drugs, thus avoiding much of the risk and expense associated with new drug discovery.

Theratech Headquarter Location

417 Wakara Way

Salt Lake City, Utah, 84108,

United States

(801)583-6028

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was Theratech founded?

    Theratech was founded in 1985.

  • Where is Theratech's headquarters?

    Theratech's headquarters is located at 417 Wakara Way, Salt Lake City.

  • What is Theratech's latest funding round?

    Theratech's latest funding round is PIPE.

  • Who are the investors of Theratech?

    Investors of Theratech include SR One.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.